We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Robust System Offers High Multiplexing Capabilities

By LabMedica International staff writers
Posted on 25 Nov 2008
A robust multiplexing system for medium and high volume laboratories measures up to 500 analytes in a single well.

Called the FlexMap 3D system, the new technology provides both protein and nucleic acid applications on one platform, and has applications in market segments such as molecular diagnostics, HLA testing, life science research, and markets as diverse as biodefense, animal health, and agro-biotech.

Designed by Luminex Corporation (Austin, TX, USA) the FlexMap 3D (three dimensional) is suitable for clinical reference labs, pharmaceutic labs, and academic core labs that are interested in enhanced workflow and higher multiplexing capabilities using the company's xMap bead-based technology. The new instrument displays improved analytical performance, front-end automation, and enhanced throughput. It is built on flow cytometry, microspheres, lasers, digital signal processing, and traditional chemistry. Featuring a flexible, open-architecture design, xMap technology can be configured to perform a wide variety of bioassays quickly, cost-effectively, and accurately.

"We are very excited to announce our first commercial shipment of FlexMap 3D," said Douglas Bryant, executive vice president and COO of Luminex. "The increased speed, increased multiplexing capabilities, as well as the improved workflow of the instrument will offer researchers and clinicians rapid and accurate results to improve the health and well-being of people around the world." Full market release of the instrument is expected in the first quarter of 2009.

The Luminex systems are flexible analyzers based on the principles of three-dimensional bead arrays. Due to the enhanced liquid kinetics of the microspheres in solution, these arrays offer superior uniformity and faster reaction times than standard two-dimensional planar arrays. The proprietary microsphere dyeing process also provides higher levels of multiplexing than traditional methods like enzyme-linked immunosorbant assays (ELISAs) or the real-time polymerase chain reaction (RT-PCR). Luminex licenses its instruments and array-based assays to companies in clinical diagnostics and biologic research

Related Links:
Luminex Corporation



New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Unit-Dose Packaging solution
HLX
New
Chlamydia Test Kit
CHLAMYTOP
New
Automated Nucleic Acid Extractor
eLab
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The FDA clearance for the QIAstat-Dx Respiratory Panel Mini test follows the recent approval of QIAstat-Dx Respiratory Panel Plus (Photo courtesy of QIAGEN)

Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings

Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.